Tag: Johnson
Lung Cancer Drug by Johnson & Johnson Boosts Survival Rate
Johnson & Johnson's Breakthrough Lung Cancer Drug Shows Promise in Boosting Survival RatesIn a groundbreaking development in the fight against non-small cell lung cancer,...
First Drug Approval: Johnson & Johnson Targets Smoldering Myeloma Treatment
Johnson & Johnson Seeks Drug Approval for Smoldering Myeloma TreatmentJohnson & Johnson is making waves in the medical community with their recent push for...
J&J Plan to Switch Payments for 340B Hospitals Rejected by U.S. Agency
The U.S. Health Resources and Services Administration has rejected a plan by Johnson & Johnson to change payment methods for hospitals participating in the...
Rising Covid Cases: Vaccine Timing Concerns
As Covid cases continue to rise this summer, concerns are growing over the timing of the upcoming rollout of updated vaccines in the fall....
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
